Caresyntax
PrivateLast Round
Series C
Extension
Aug 15, 2024
Total Funding Raised
$279.4M
Company Overview
Caresyntax is a healthcare technology company that offers a vendor-neutral, data-driven surgery platform designed to provide actionable insights for enhancing the safety and efficiency of surgical procedures.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Quality Management, Vertical SaaS, Health IoT
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caresyntax Comps
Public and private peers based on sector, stage, and business model.
Caresyntax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Aug 15, 2024 | ||||
| Series C | Feb 14, 2024 | ||||
| Series C Extension | Sep 16, 2021 | ||||
| Series C | Apr 28, 2021 | ||||
| VC Round | Dec 17, 2019 | ||||
Debt | Jul 1, 2019 |
Key People
Founding team and executive leadership
Caresyntax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norgine Ventures | Series A |
| Novacap | Series C Extension |
| IPF Partners | Debt, Series C Extension, Series C, VC Round |
| Almak Capital | VC Round |
| Vesalius Biocapital III | Series C |
| BlackRock Innovation Capital | Series C Extension |
| Cure Capital Advisors | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2025
Launched Clinical Data as a Service (CDaaS) for healthcare and life sciences.
- Sep 8, 2025
Partnered with Paragonix Technologies to expand Real-World Evidence in transplantation.
Caresyntax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Caresyntax's valuation, stock price, and market status.
